VRTX
Vertex Pharmaceuticals, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$469.34
-8.79 ▼ -1.84%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$468.84
-0.50 ▼ -0.11%
| Index | NDX, S&P 500 | P/E | 30.61 | EPS (ttm) | 15.33 | Insider Own | 0.33% | Shs Outstand | 0.25B | Perf Week | 2.77% |
| Market Cap | 119.23B | Forward P/E | 21.13 | EPS next Y | 14.98% | Insider Trans | -27.22% | Shs Float | 0.25B | Perf Month | 1.76% |
| Enterprise Value | 114.65B | PEG | 1.96 | EPS next Q | 4.47 | Inst Own | 94.17% | Short Float | 1.75% | Perf Quarter | 5.56% |
| Income | 3.95B | P/S | 9.87 | EPS this Y | 4.98% | Inst Trans | 0.01% | Short Ratio | 3.02 | Perf Half Y | 18.11% |
| Sales | 12.07B | P/B | 6.39 | EPS next 5Y | 10.79% | ROA | 16.06% | Short Interest | 4.43M | Perf YTD | 3.52% |
| Book/sh | 73.49 | P/C | 18.03 | EPS past 3/5Y | 6.12% 8.28% | ROE | 22.54% | 52W High | -9.69% ($519.68) | Perf Year | -6.68% |
| Cash/sh | 26.02 | P/FCF | 37.33 | Sales past 3/5Y | 11.34% 14.23% | ROIC | 19.17% | 52W Low | 29.47% ($362.50) | Perf 3Y | 59.93% |
| Dividend Est. | - | EV/EBITDA | 23.08 | EPS Y/Y TTM | 848.3% | Gross Margin | 86.32% | Volatility(W/M) | 3.38% 3.11% | Perf 5Y | 118.98% |
| Dividend TTM | - | EV/Sales | 9.5 | Sales Y/Y TTM | 9.92% | Oper. Margin | 39.43% | ATR (14) | 15.58 | Perf 10Y | 444.1% |
| Dividend Ex-Date | - | Quick Ratio | 2.46 | EPS Q/Q | 32.7% | Profit Margin | 32.74% | RSI (14) | 47.94 | Recom | 1.66 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.9 | Sales Q/Q | 11.76% | SMA20 | -1.91% ($478.48) | Beta | 0.33 | Target Price | $551.52 |
| Payout | - | Debt/Eq | 0.11 | Earnings | 2000000 | SMA50 | -0.03% ($469.48) | Rel Volume | 0.75 | Prev Close | $478.13 |
| Employees | 6400 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | -1.58% 0.18% | SMA200 | 7.11% ($438.19) | Avg Volume(3M) | 1.47M | Price | $469.34 |
| IPO | 1991/7/24 | Option/Short | Yes/Yes | Trades | 28298 | Volume | 1,097,554 | Change | -1.84% |
뉴스 로딩 중...